Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial

Aims: The efficacy of antiplatelet therapy may vary among different disease subtypes. Prasugrel is generally a more potent, consistent, and fast-acting platelet inhibitor than clopidogrel. This sub-analysis of the phase III comparison of PRAsugrel and clopidogrel in Japanese patients with ischemic S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Kitazono, Takanari, Toyoda, Kazunori, Kitagawa, Kazuo, Nagao, Takehiko, Yamagami, Hiroshi, Uchiyama, Shinichiro, Tanahashi, Norio, Matsumoto, Masayasu, Minematsu, Kazuo, Nagata, Izumi, Nishikawa, Masakatsu, Nanto, Shinsuke, Ikeda, Yasuo, Shirai, Toshiaki, Abe, Kenji, Ogawa, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957026/
https://ncbi.nlm.nih.gov/pubmed/32493881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.56093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados